import{d as R,u as w,r as u,q as H,o as D,g,a as P,c as d,b as t,e as y,F as b,f as v,n as I,h as s,p as h,t as i,i as p,s as _,j as V,w as B,k as G,v as U,x as F,y as Y,l as A,_ as z}from"./index-BJ22ZfUs.js";const q={class:"min-h-screen pt-24 relative overflow-hidden"},j={class:"fixed inset-0 z-0 pointer-events-none overflow-hidden"},W={class:"relative z-10 px-6 py-12"},J={class:"mx-auto max-w-7xl"},K={class:"space-y-24"},$={class:"relative grid lg:grid-cols-2 gap-8 p-8 lg:p-12"},Q={class:"mb-4"},Z={class:"mb-2 text-3xl font-bold text-[rgb(var(--text-heading))] lg:text-4xl"},X={class:"mb-4 text-[rgb(var(--text-muted))] flex items-center gap-2"},e0={class:"mb-6 text-lg text-[rgb(var(--text-body))] leading-relaxed"},t0={key:0,class:"mb-8 p-4 rounded-xl bg-[rgb(var(--bg-card-muted))/0.5] border border-[rgb(var(--border-muted))/0.5]"},a0={class:"text-xs text-[rgb(var(--text-muted))] uppercase tracking-wider mb-2"},r0={class:"grid grid-cols-3 gap-4"},o0={class:"text-xs text-[rgb(var(--text-muted))]"},l0={class:"relative"},n0={key:0,class:"rounded-2xl border border-[rgb(var(--border-muted))/0.5] bg-[rgb(var(--bg-card))/0.8] p-4 shadow-lg shadow-emerald-500/10"},s0={class:"flex flex-wrap gap-2 mb-4"},i0=["onClick"],d0={class:"overflow-x-auto"},A0={class:"w-full text-sm"},c0={class:"py-2 px-2 text-[rgb(var(--text-heading))] font-medium text-xs"},p0={class:"inline-flex items-center gap-2"},b0={class:"w-5 h-5 rounded-full bg-emerald-500/20 text-emerald-400 text-xs flex items-center justify-center font-bold"},v0={class:"py-2 px-2 text-center"},x0={class:"text-emerald-400 font-mono font-bold"},u0={class:"py-2 px-2 text-center text-[rgb(var(--text-primary))]"},g0={class:"py-2 px-2 text-center"},m0={class:"px-2 py-0.5 rounded-full bg-emerald-500/10 text-emerald-400 text-xs font-medium"},C0={class:"mt-4 pt-3 border-t border-[rgb(var(--border-muted))/0.5] flex items-center justify-between"},T0={class:"text-xs text-[rgb(var(--text-muted))]"},O0={key:1,class:"relative rounded-2xl overflow-hidden border border-[rgb(var(--border-muted))/0.5] bg-[rgb(var(--bg-card))/0.8] p-4 shadow-lg shadow-cyan-500/10"},M0={key:0,class:"absolute inset-0 flex items-center justify-center bg-[rgb(var(--bg-card))]"},f0={class:"text-center"},y0=["onMouseenter","onMouseleave"],h0={class:"absolute bottom-4 left-4 right-4 flex items-center justify-between",style:{"z-index":"100"}},N0={class:"flex items-center gap-2"},E0=["onClick"],k0={class:"relative z-10 px-6 py-32"},L0={class:"mx-auto max-w-4xl"},S0={class:"relative rounded-3xl border border-[rgb(var(--border-primary))] bg-gradient-to-br from-[rgb(var(--bg-card))] via-[rgb(var(--bg-card))/0.95] to-[rgb(var(--bg-card))] p-12 text-center overflow-hidden"},R0={class:"relative"},w0={class:"flex flex-wrap justify-center gap-4"},H0=R({__name:"CaseStudiesPage",setup(D0){w({title:"Case Studies",description:"Explore AI-designed therapeutics with interactive 3D molecular viewers. See proven results including COVID-19 drug discovery, GPR-139 agonist design, and Equi-mRNA benchmarks.",path:"/case-studies"});const{isDark:C}=Y(),T=u([]);let c=[];const N={glp1:`HEADER    PEPTIDE HORMONE                        01-JAN-25   XXXX
TITLE     GLP-1 AGONIST OPTIMIZED BY DEEPBIO SCIENTIFIC AI
ATOM      1  N   HIS A   1       0.000   0.000   0.000  1.00 20.00           N
ATOM      2  CA  HIS A   1       1.458   0.000   0.000  1.00 20.00           C
ATOM      3  C   HIS A   1       2.009   1.420   0.000  1.00 20.00           C
ATOM      4  O   HIS A   1       1.251   2.390   0.000  1.00 20.00           O
ATOM      5  CB  HIS A   1       1.990  -0.771   1.219  1.00 20.00           C
ATOM      6  N   ALA A   2       3.327   1.542   0.000  1.00 20.00           N
ATOM      7  CA  ALA A   2       3.974   2.851   0.000  1.00 20.00           C
ATOM      8  C   ALA A   2       5.481   2.726  -0.156  1.00 20.00           C
ATOM      9  O   ALA A   2       6.032   1.622  -0.266  1.00 20.00           O
ATOM     10  CB  ALA A   2       3.643   3.688   1.234  1.00 20.00           C
ATOM     11  N   GLU A   3       6.128   3.894  -0.156  1.00 20.00           N
ATOM     12  CA  GLU A   3       7.577   3.970  -0.306  1.00 20.00           C
ATOM     13  C   GLU A   3       8.094   5.394  -0.156  1.00 20.00           C
ATOM     14  O   GLU A   3       7.299   6.338  -0.054  1.00 20.00           O
ATOM     15  CB  GLU A   3       8.252   3.062  -1.338  1.00 20.00           C
ATOM     16  N   GLY A   4       9.410   5.545  -0.156  1.00 20.00           N
ATOM     17  CA  GLY A   4      10.024   6.867  -0.007  1.00 20.00           C
ATOM     18  C   GLY A   4      11.534   6.766   0.106  1.00 20.00           C
ATOM     19  O   GLY A   4      12.077   5.662   0.216  1.00 20.00           O
ATOM     20  N   THR A   5      12.193   7.925   0.095  1.00 20.00           N
ATOM     21  CA  THR A   5      13.641   7.973   0.201  1.00 20.00           C
ATOM     22  C   THR A   5      14.147   9.396   0.095  1.00 20.00           C
ATOM     23  O   THR A   5      13.343  10.329  -0.015  1.00 20.00           O
ATOM     24  CB  THR A   5      14.317   7.039   1.209  1.00 20.00           C
ATOM     25  N   PHE A   6      15.463   9.549   0.095  1.00 20.00           N
ATOM     26  CA  PHE A   6      16.066  10.874   0.000  1.00 20.00           C
ATOM     27  C   PHE A   6      17.576  10.753  -0.156  1.00 20.00           C
ATOM     28  O   PHE A   6      18.127   9.649  -0.266  1.00 20.00           O
ATOM     29  CB  PHE A   6      15.735  11.775   1.178  1.00 20.00           C
ATOM     30  N   THR A   7      18.224  11.921  -0.156  1.00 20.00           N
ATOM     31  CA  THR A   7      19.672  12.027  -0.301  1.00 20.00           C
ATOM     32  C   THR A   7      20.189  13.451  -0.156  1.00 20.00           C
ATOM     33  O   THR A   7      19.395  14.395  -0.054  1.00 20.00           O
ATOM     34  CB  THR A   7      20.347  11.093   1.209  1.00 20.00           C
ATOM     35  N   SER A   8      21.505  13.602  -0.156  1.00 20.00           N
ATOM     36  CA  SER A   8      22.119  14.924  -0.007  1.00 20.00           C
ATOM     37  C   SER A   8      23.629  14.823   0.106  1.00 20.00           C
ATOM     38  O   SER A   8      24.171  13.719   0.216  1.00 20.00           O
ATOM     39  CB  SER A   8      21.788  15.825   1.178  1.00 20.00           C
ATOM     40  N   ASP A   9      24.288  15.982   0.095  1.00 20.00           N
ATOM     41  CA  ASP A   9      25.736  16.088   0.201  1.00 20.00           C
ATOM     42  C   ASP A   9      26.242  17.510   0.095  1.00 20.00           C
ATOM     43  O   ASP A   9      25.438  18.444  -0.015  1.00 20.00           O
ATOM     44  CB  ASP A   9      26.412  15.180  -0.838  1.00 20.00           C
ATOM     45  N   VAL A  10      27.558  17.663   0.095  1.00 20.00           N
ATOM     46  CA  VAL A  10      28.161  18.988   0.000  1.00 20.00           C
ATOM     47  C   VAL A  10      29.671  18.867  -0.156  1.00 20.00           C
ATOM     48  O   VAL A  10      30.222  17.763  -0.266  1.00 20.00           O
ATOM     49  CB  VAL A  10      27.830  19.889   1.178  1.00 20.00           C
END`,proteinBinder:`HEADER    PROTEIN BINDER                         01-JAN-25   YYYY
TITLE     DE NOVO PROTEIN BINDER - ONCOLOGY TARGET
ATOM      1  N   MET A   1       0.000   0.000   0.000  1.00 15.00           N
ATOM      2  CA  MET A   1       1.458   0.000   0.000  1.00 15.00           C
ATOM      3  C   MET A   1       2.009   1.420   0.000  1.00 15.00           C
ATOM      4  O   MET A   1       1.251   2.390   0.000  1.00 15.00           O
ATOM      5  CB  MET A   1       1.990  -0.771   1.219  1.00 15.00           C
ATOM      6  N   ARG A   2       3.327   1.542   0.000  1.00 15.00           N
ATOM      7  CA  ARG A   2       3.974   2.851   0.000  1.00 15.00           C
ATOM      8  C   ARG A   2       5.481   2.726  -0.156  1.00 15.00           C
ATOM      9  O   ARG A   2       6.032   1.622  -0.266  1.00 15.00           O
ATOM     10  CB  ARG A   2       3.643   3.688   1.234  1.00 15.00           C
ATOM     11  N   TRP A   3       6.128   3.894  -0.156  1.00 15.00           N
ATOM     12  CA  TRP A   3       7.577   3.970  -0.306  1.00 15.00           C
ATOM     13  C   TRP A   3       8.094   5.394  -0.156  1.00 15.00           C
ATOM     14  O   TRP A   3       7.299   6.338  -0.054  1.00 15.00           O
ATOM     15  CB  TRP A   3       8.252   3.062   0.738  1.00 15.00           C
ATOM     16  N   LYS A   4       9.410   5.545  -0.156  1.00 15.00           N
ATOM     17  CA  LYS A   4      10.024   6.867  -0.007  1.00 15.00           C
ATOM     18  C   LYS A   4      11.534   6.766   0.106  1.00 15.00           C
ATOM     19  O   LYS A   4      12.077   5.662   0.216  1.00 15.00           O
ATOM     20  CB  LYS A   4      9.693   7.768   1.178  1.00 15.00           C
ATOM     21  N   LEU A   5      12.193   7.925   0.095  1.00 15.00           N
ATOM     22  CA  LEU A   5      13.641   7.973   0.201  1.00 15.00           C
ATOM     23  C   LEU A   5      14.147   9.396   0.095  1.00 15.00           C
ATOM     24  O   LEU A   5      13.343  10.329  -0.015  1.00 15.00           O
ATOM     25  CB  LEU A   5      14.317   7.039  -0.838  1.00 15.00           C
ATOM     26  N   ASN A   6      15.463   9.549   0.095  1.00 15.00           N
ATOM     27  CA  ASN A   6      16.066  10.874   0.000  1.00 15.00           C
ATOM     28  C   ASN A   6      17.576  10.753  -0.156  1.00 15.00           C
ATOM     29  O   ASN A   6      18.127   9.649  -0.266  1.00 15.00           O
ATOM     30  CB  ASN A   6      15.735  11.775   1.178  1.00 15.00           C
ATOM     31  N   GLN A   7      18.224  11.921  -0.156  1.00 15.00           N
ATOM     32  CA  GLN A   7      19.672  12.027  -0.301  1.00 15.00           C
ATOM     33  C   GLN A   7      20.189  13.451  -0.156  1.00 15.00           C
ATOM     34  O   GLN A   7      19.395  14.395  -0.054  1.00 15.00           O
ATOM     35  CB  GLN A   7      20.347  11.093   0.738  1.00 15.00           C
ATOM     36  N   CYS A   8      21.505  13.602  -0.156  1.00 15.00           N
ATOM     37  CA  CYS A   8      22.119  14.924  -0.007  1.00 15.00           C
ATOM     38  C   CYS A   8      23.629  14.823   0.106  1.00 15.00           C
ATOM     39  O   CYS A   8      24.171  13.719   0.216  1.00 15.00           O
ATOM     40  CB  CYS A   8      21.788  15.825   1.178  1.00 15.00           C
ATOM     41  SG  CYS A   8      22.350  15.150   2.800  1.00 15.00           S
END`,cmpNeu5Ac:`HEADER    SMALL MOLECULE - CMP-NEU5AC              01-JAN-25   CMNA
TITLE     CYTIDINE-5-MONOPHOSPHO-N-ACETYLNEURAMINIC ACID - COVID-19 INHIBITOR
HETATM    1  C1  CMN A   1       0.000   0.000   0.000  1.00 20.00           C
HETATM    2  C2  CMN A   1       1.400   0.000   0.500  1.00 20.00           C
HETATM    3  O2  CMN A   1       1.600   1.200   1.200  1.00 20.00           O
HETATM    4  C3  CMN A   1       2.400  -0.200  -0.600  1.00 20.00           C
HETATM    5  O3  CMN A   1       2.200  -1.400  -1.300  1.00 20.00           O
HETATM    6  C4  CMN A   1       3.800   0.000  -0.100  1.00 20.00           C
HETATM    7  O4  CMN A   1       4.000   1.400   0.100  1.00 20.00           O
HETATM    8  C5  CMN A   1       4.800  -0.600  -1.000  1.00 20.00           C
HETATM    9  N5  CMN A   1       4.600  -2.000  -1.200  1.00 20.00           N
HETATM   10  C10 CMN A   1       5.400  -2.800  -2.000  1.00 20.00           C
HETATM   11  O10 CMN A   1       6.400  -2.400  -2.600  1.00 20.00           O
HETATM   12  C11 CMN A   1       5.000  -4.200  -2.200  1.00 20.00           C
HETATM   13  C6  CMN A   1       6.200  -0.200  -0.500  1.00 20.00           C
HETATM   14  O6  CMN A   1       6.400   1.200  -0.300  1.00 20.00           O
HETATM   15  C7  CMN A   1       7.200  -0.800  -1.400  1.00 20.00           C
HETATM   16  O7  CMN A   1       7.000  -2.200  -1.600  1.00 20.00           O
HETATM   17  C8  CMN A   1       8.600  -0.400  -0.900  1.00 20.00           C
HETATM   18  O8  CMN A   1       8.800   1.000  -0.700  1.00 20.00           O
HETATM   19  C9  CMN A   1       9.600  -1.000  -1.800  1.00 20.00           C
HETATM   20  O9  CMN A   1       9.400  -2.400  -2.000  1.00 20.00           O
HETATM   21  P   CMN A   1      -1.200   0.600   0.800  1.00 20.00           P
HETATM   22  O1P CMN A   1      -1.000   2.000   1.200  1.00 20.00           O
HETATM   23  O2P CMN A   1      -2.400   0.400   0.000  1.00 20.00           O
HETATM   24  O3P CMN A   1      -1.400  -0.200   2.000  1.00 20.00           O
HETATM   25  C1R CMN A   1      -3.600   0.800  -0.600  1.00 20.00           C
HETATM   26  C2R CMN A   1      -4.600   1.600   0.200  1.00 20.00           C
HETATM   27  O2R CMN A   1      -4.400   3.000   0.000  1.00 20.00           O
HETATM   28  C3R CMN A   1      -6.000   1.200  -0.200  1.00 20.00           C
HETATM   29  O3R CMN A   1      -6.200  -0.200  -0.400  1.00 20.00           O
HETATM   30  C4R CMN A   1      -7.000   1.800   0.700  1.00 20.00           C
HETATM   31  O4R CMN A   1      -3.800   1.400  -1.800  1.00 20.00           O
HETATM   32  N1  CMN A   1      -8.400   1.400   0.300  1.00 20.00           N
HETATM   33  C2N CMN A   1      -9.400   2.200   0.800  1.00 20.00           C
HETATM   34  O2N CMN A   1      -9.200   3.200   1.500  1.00 20.00           O
HETATM   35  N3  CMN A   1     -10.600   1.800   0.400  1.00 20.00           N
HETATM   36  C4N CMN A   1     -10.800   0.600  -0.200  1.00 20.00           C
HETATM   37  N4  CMN A   1     -12.000   0.200  -0.600  1.00 20.00           N
HETATM   38  C5N CMN A   1      -9.800  -0.200  -0.600  1.00 20.00           C
HETATM   39  C6N CMN A   1      -8.600   0.200  -0.200  1.00 20.00           C
END`,mrnaVaccine:`HEADER    mRNA CONSTRUCT                          01-JAN-25   ZZZZ
TITLE     NEOANTIGEN PEPTIDE FOR CANCER VACCINE
ATOM      1  N   ALA A   1       0.000   0.000   0.000  1.00 25.00           N
ATOM      2  CA  ALA A   1       1.458   0.000   0.000  1.00 25.00           C
ATOM      3  C   ALA A   1       2.009   1.420   0.000  1.00 25.00           C
ATOM      4  O   ALA A   1       1.251   2.390   0.000  1.00 25.00           O
ATOM      5  CB  ALA A   1       1.990  -0.771   1.219  1.00 25.00           C
ATOM      6  N   ILE A   2       3.327   1.542   0.000  1.00 25.00           N
ATOM      7  CA  ILE A   2       3.974   2.851   0.000  1.00 25.00           C
ATOM      8  C   ILE A   2       5.481   2.726  -0.156  1.00 25.00           C
ATOM      9  O   ILE A   2       6.032   1.622  -0.266  1.00 25.00           O
ATOM     10  CB  ILE A   2       3.643   3.688   1.234  1.00 25.00           C
ATOM     11  N   TYR A   3       6.128   3.894  -0.156  1.00 25.00           N
ATOM     12  CA  TYR A   3       7.577   3.970  -0.306  1.00 25.00           C
ATOM     13  C   TYR A   3       8.094   5.394  -0.156  1.00 25.00           C
ATOM     14  O   TYR A   3       7.299   6.338  -0.054  1.00 25.00           O
ATOM     15  CB  TYR A   3       8.252   3.062   0.738  1.00 25.00           C
ATOM     16  N   PHE A   4       9.410   5.545  -0.156  1.00 25.00           N
ATOM     17  CA  PHE A   4      10.024   6.867  -0.007  1.00 25.00           C
ATOM     18  C   PHE A   4      11.534   6.766   0.106  1.00 25.00           C
ATOM     19  O   PHE A   4      12.077   5.662   0.216  1.00 25.00           O
ATOM     20  CB  PHE A   4       9.693   7.768   1.178  1.00 25.00           C
ATOM     21  N   PRO A   5      12.193   7.925   0.095  1.00 25.00           N
ATOM     22  CA  PRO A   5      13.641   7.973   0.201  1.00 25.00           C
ATOM     23  C   PRO A   5      14.147   9.396   0.095  1.00 25.00           C
ATOM     24  O   PRO A   5      13.343  10.329  -0.015  1.00 25.00           O
ATOM     25  CB  PRO A   5      14.317   7.039  -0.838  1.00 25.00           C
ATOM     26  N   GLU A   6      15.463   9.549   0.095  1.00 25.00           N
ATOM     27  CA  GLU A   6      16.066  10.874   0.000  1.00 25.00           C
ATOM     28  C   GLU A   6      17.576  10.753  -0.156  1.00 25.00           C
ATOM     29  O   GLU A   6      18.127   9.649  -0.266  1.00 25.00           O
ATOM     30  CB  GLU A   6      15.735  11.775   1.178  1.00 25.00           C
ATOM     31  N   LYS A   7      18.224  11.921  -0.156  1.00 25.00           N
ATOM     32  CA  LYS A   7      19.672  12.027  -0.301  1.00 25.00           C
ATOM     33  C   LYS A   7      20.189  13.451  -0.156  1.00 25.00           C
ATOM     34  O   LYS A   7      19.395  14.395  -0.054  1.00 25.00           O
ATOM     35  CB  LYS A   7      20.347  11.093   0.738  1.00 25.00           C
ATOM     36  N   VAL A   8      21.505  13.602  -0.156  1.00 25.00           N
ATOM     37  CA  VAL A   8      22.119  14.924  -0.007  1.00 25.00           C
ATOM     38  C   VAL A   8      23.629  14.823   0.106  1.00 25.00           C
ATOM     39  O   VAL A   8      24.171  13.719   0.216  1.00 25.00           O
ATOM     40  CB  VAL A   8      21.788  15.825   1.178  1.00 25.00           C
END`,gpr139Binder:`HEADER    GPR-139 SELECTIVE AGONIST                01-JAN-25   GPR1
TITLE     DE NOVO GPR-139 BINDER - ALPHAFOLD PREDICTED STRUCTURE
ATOM      1  N   VAL A   1     -32.179   9.477 -24.112  1.00 76.87           N
ATOM      2  CA  VAL A   1     -30.753   9.821 -24.348  1.00 86.25           C
ATOM      3  C   VAL A   1     -30.065  10.338 -23.080  1.00 86.86           C
ATOM      4  O   VAL A   1     -29.012   9.816 -22.734  1.00 85.12           O
ATOM      5  N   ALA A   2     -30.679  11.262 -22.331  1.00 84.53           N
ATOM      6  CA  ALA A   2     -30.104  11.788 -21.082  1.00 89.39           C
ATOM      7  C   ALA A   2     -29.867  10.718 -19.995  1.00 90.46           C
ATOM      8  O   ALA A   2     -28.827  10.712 -19.349  1.00 88.18           O
ATOM      9  N   PHE A   3     -30.783   9.751 -19.827  1.00 89.25           N
ATOM     10  CA  PHE A   3     -30.658   8.664 -18.852  1.00 88.58           C
ATOM     11  C   PHE A   3     -29.439   7.762 -19.106  1.00 88.87           C
ATOM     12  O   PHE A   3     -28.699   7.441 -18.178  1.00 88.47           O
ATOM     13  N   VAL A   4     -29.169   7.394 -20.356  1.00 89.25           N
ATOM     14  CA  VAL A   4     -28.019   6.553 -20.737  1.00 89.08           C
ATOM     15  C   VAL A   4     -26.691   7.289 -20.504  1.00 88.63           C
ATOM     16  O   VAL A   4     -25.731   6.677 -20.053  1.00 88.62           O
ATOM     17  N   LYS A   5     -26.657   8.608 -20.747  1.00 90.16           N
ATOM     18  CA  LYS A   5     -25.476   9.448 -20.510  1.00 87.33           C
ATOM     19  C   LYS A   5     -25.121   9.530 -19.015  1.00 86.26           C
ATOM     20  O   LYS A   5     -23.980   9.258 -18.662  1.00 88.96           O
ATOM     21  N   ASN A   6     -26.114   9.747 -18.141  1.00 92.49           N
ATOM     22  CA  ASN A   6     -25.914   9.749 -16.684  1.00 91.99           C
ATOM     23  C   ASN A   6     -25.444   8.386 -16.156  1.00 92.64           C
ATOM     24  O   ASN A   6     -24.608   8.324 -15.261  1.00 92.53           O
ATOM     25  N   TRP A   7     -25.943   7.271 -16.712  1.00 91.40           N
ATOM     26  CA  TRP A   7     -25.491   5.930 -16.338  1.00 90.44           C
ATOM     27  C   TRP A   7     -24.031   5.670 -16.725  1.00 90.93           C
ATOM     28  O   TRP A   7     -23.287   5.105 -15.929  1.00 91.92           O
ATOM     29  N   LEU A   8     -23.608   6.122 -17.914  1.00 92.86           N
ATOM     30  CA  LEU A   8     -22.215   6.013 -18.366  1.00 92.19           C
ATOM     31  C   LEU A   8     -21.271   6.864 -17.511  1.00 92.28           C
ATOM     32  O   LEU A   8     -20.201   6.388 -17.145  1.00 93.72           O
ATOM     33  N   GLU A   9     -21.665   8.082 -17.125  1.00 91.30           N
ATOM     34  CA  GLU A   9     -20.890   8.952 -16.234  1.00 91.30           C
ATOM     35  C   GLU A   9     -20.765   8.344 -14.826  1.00 91.52           C
ATOM     36  O   GLU A   9     -19.672   8.332 -14.264  1.00 92.30           O
ATOM     37  N   PHE A  10     -21.835   7.760 -14.287  1.00 93.67           N
ATOM     38  CA  PHE A  10     -21.808   7.052 -13.007  1.00 92.09           C
ATOM     39  C   PHE A  10     -20.880   5.829 -13.042  1.00 92.33           C
ATOM     40  O   PHE A  10     -20.072   5.646 -12.133  1.00 92.92           O
ATOM     41  N   LEU A  11     -20.946   5.010 -14.097  1.00 93.90           N
ATOM     42  CA  LEU A  11     -20.047   3.864 -14.288  1.00 92.40           C
ATOM     43  C   LEU A  11     -18.587   4.296 -14.392  1.00 92.29           C
ATOM     44  O   LEU A  11     -17.724   3.682 -13.760  1.00 93.90           O
ATOM     45  N   ALA A  12     -18.293   5.364 -15.134  1.00 92.66           N
ATOM     46  CA  ALA A  12     -16.942   5.897 -15.270  1.00 91.62           C
ATOM     47  C   ALA A  12     -16.394   6.407 -13.929  1.00 91.38           C
ATOM     48  O   ALA A  12     -15.260   6.076 -13.565  1.00 90.63           O
ATOM     49  N   GLN A  13     -17.195   7.121 -13.137  1.00 94.44           N
ATOM     50  CA  GLN A  13     -16.812   7.569 -11.798  1.00 93.77           C
ATOM     51  C   GLN A  13     -16.609   6.397 -10.835  1.00 93.93           C
ATOM     52  O   GLN A  13     -15.632   6.379 -10.089  1.00 93.82           O
ATOM     53  N   TRP A  14     -17.471   5.376 -10.872  1.00 95.37           N
ATOM     54  CA  TRP A  14     -17.350   4.193 -10.031  1.00 94.49           C
END`},O={"Spike-ACE2":[{drug:"Oseltamivir phosphate",pIC50:8.29,rankFDA:42,rankAntiviral:1},{drug:"Etravirine",pIC50:8.22,rankFDA:52,rankAntiviral:2},{drug:"Fosamprenavir calcium",pIC50:8.2,rankFDA:57,rankAntiviral:3},{drug:"Tipranavir",pIC50:7.94,rankFDA:108,rankAntiviral:4},{drug:"Elvitegravir",pIC50:7.88,rankFDA:141,rankAntiviral:5}],Helicase:[{drug:"Fosamprenavir calcium (FPV)",pIC50:7.51,rankFDA:21,rankAntiviral:1},{drug:"Simeprevir",pIC50:7.47,rankFDA:24,rankAntiviral:2},{drug:"Elvitegravir",pIC50:7.28,rankFDA:52,rankAntiviral:3},{drug:"Simeprevir sodium",pIC50:7.11,rankFDA:87,rankAntiviral:4},{drug:"Ritonavir",pIC50:7.01,rankFDA:120,rankAntiviral:6}],"3C-like":[{drug:"Fosamprenavir calcium",pIC50:7.72,rankFDA:5,rankAntiviral:1},{drug:"Elvitegravir",pIC50:7.25,rankFDA:29,rankAntiviral:2},{drug:"Tipranavir",pIC50:7.17,rankFDA:37,rankAntiviral:3},{drug:"Asunaprevir",pIC50:7.08,rankFDA:46,rankAntiviral:4},{drug:"Atazanavir sulfate",pIC50:6.92,rankFDA:68,rankAntiviral:6}],RdRp:[{drug:"Elvitegravir",pIC50:7.6,rankFDA:8,rankAntiviral:1},{drug:"Fosamprenavir calcium",pIC50:7.24,rankFDA:24,rankAntiviral:2},{drug:"Ritonavir",pIC50:6.96,rankFDA:53,rankAntiviral:3},{drug:"Asunaprevir",pIC50:6.9,rankFDA:66,rankAntiviral:4},{drug:"Simeprevir sodium",pIC50:6.87,rankFDA:71,rankAntiviral:5}]},M=[{id:1,title:"COVID-19 Drug Discovery: CMP-Neu5Ac",partner:"University Lab",category:"Antiviral Discovery",sequence:"CC(=O)N[C@@H]1[C@@H](O)C[C@@](OC2O[C@H](COP(O)(=O)O)[C@@H](O)[C@H]2O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO",moleculeType:"smallMolecule",description:"Identified Cytidine-5'-monophospho-N-acetylneuraminic acid sodium salt (CMP-Neu5Ac) as a SARS-CoV-2 Spike Protein inhibitor through AI-driven molecular docking. Wet lab validated by University Materials Science Lab.",results:[{metric:"Validated",label:"Wet Lab Confirmation"},{metric:"Spike RBD",label:"Target Binding Site"},{metric:"In Vitro",label:"Confirmed Inhibition"}],color:"purple",gradient:"from-purple-500 to-blue-500",pdbKey:"cmpNeu5Ac",viewerStyle:{stick:{colorscheme:"purpleCarbon",radius:.2},sphere:{colorscheme:"Jmol",scale:.25}}},{id:2,title:"COVID-19 Drug Repurposing: FDA-Approved Antivirals",partner:"AttentionSite-Augmented DeepDTA",category:"Drug Repurposing",sequence:"",moleculeType:"drugTable",description:"Top FDA-approved antiviral drugs predicted by AttentionSite-Augmented DeepDTA model to have highest affinity scores with 4 SARS-CoV-2 genome sequences. Identified candidates like Fosamprenavir, Elvitegravir, and Ritonavir as potential COVID-19 treatments.",results:[{metric:"3416",label:"FDA Drugs Screened"},{metric:"4",label:"Viral Targets"},{metric:"85",label:"Antivirals Ranked"}],color:"emerald",gradient:"from-emerald-500 to-teal-500",pdbKey:null,viewerStyle:null},{id:3,title:"GPR-139 Selective Agonist: De Novo Design",partner:"DeepBio Scientific AI Platform",category:"De Novo Peptide Design",sequence:"VAFVKNWLEFLAQWVASRLVNHQIGLQQELQIVAQAVLRYHQAETAKLSYTLAN",moleculeType:"peptide",description:"De novo designed GPR-139 selective agonist with 40% better predicted binding score than Dynorphin. Unlike RFDiffusion (21% structural similarity), our design achieves 0% similarity to existing proteins, enabling optimization to avoid off-target binding to opioid receptors (OPRM, OPRK, OPRD).",results:[{metric:"+40%",label:"Better Binding vs Dynorphin"},{metric:"0%",label:"Structural Similarity"},{metric:"Zero",label:"Off-Target Opioid Binding"}],color:"amber",gradient:"from-amber-500 to-orange-500",pdbKey:"gpr139Binder",viewerStyle:{cartoon:{color:"spectrum"},stick:{colorscheme:"orangeCarbon",radius:.15}}},{id:4,title:"Equi-mRNA: mRNA Expression & Stability Prediction",partner:"NeurIPS 2025 Publication",category:"mRNA Language Model",sequence:"AUG·GCU·GAA·UGC·AAA·GGU·CUG·UAC·CAG·UUG·...",moleculeType:"mrnaVisualization",description:"Equi-mRNA is the first codon-level equivariant mRNA language model that explicitly encodes synonymous codon symmetries using SO(2) group theory. With only 15M parameters, it outperforms models 100x larger across multiple mRNA benchmarks.",results:[{metric:"0.855",label:"Best mRFP Score"},{metric:"0.764",label:"Best Tc-Ribo Score"},{metric:"15M",label:"Parameters (vs 1.6B)"}],color:"cyan",gradient:"from-cyan-500 to-purple-500",pdbKey:null,viewerStyle:null}];u(null);const m=u([!0,!0,!0,!0]),x=u("Spike-ACE2");async function E(){const o=await U(()=>import("./3Dmol-DljS0b8b.js").then(a=>a._),[]);await F(),M.forEach((a,n)=>{if(a.moleculeType==="drugTable"||a.moleculeType==="mrnaVisualization"){m.value[n]=!1;return}const e=T.value[n];if(!e)return;const r=o.createViewer(e,{backgroundColor:C.value?"rgba(15, 23, 42, 0.9)":"rgba(241, 245, 249, 0.9)",antialias:!0}),l=N[a.pdbKey];r.addModel(l,"pdb"),a.moleculeType==="smallMolecule"?(r.setStyle({},{stick:{colorscheme:"purpleCarbon",radius:.2},sphere:{colorscheme:"Jmol",scale:.3}}),r.addSurface(o.SurfaceType.VDW,{opacity:.25,color:"#a855f7"})):a.color==="cyan"?(r.setStyle({},{cartoon:{color:"spectrum"},stick:{colorscheme:"cyanCarbon",radius:.15}}),r.addSurface(o.SurfaceType.VDW,{opacity:.15,color:"#22d3ee"})):a.color==="purple"?(r.setStyle({},{cartoon:{color:"spectrum"},sphere:{colorscheme:"Jmol",scale:.25}}),r.addSurface(o.SurfaceType.VDW,{opacity:.15,color:"#a855f7"})):a.color==="amber"?(r.setStyle({},{cartoon:{color:"spectrum"},stick:{colorscheme:"orangeCarbon",radius:.15}}),r.addSurface(o.SurfaceType.VDW,{opacity:.15,color:"#f59e0b"})):(r.setStyle({},{cartoon:{color:"spectrum"},stick:{colorscheme:"orangeCarbon",radius:.15}}),r.addSurface(o.SurfaceType.VDW,{opacity:.15,color:"#ec4899"})),r.zoomTo(),r.render(),r.getView(),r.spin("y",.5),c[n]=r,m.value[n]=!1})}H(C,o=>{const a=o?"rgba(15, 23, 42, 0.9)":"rgba(241, 245, 249, 0.9)";c.forEach(n=>{n&&(n.setBackgroundColor(a),n.render())})});function k(o){c[o]&&c[o].spin(!1)}function L(o){c[o]&&c[o].spin("y",.5)}function S(o){const a=c[o];if(a){a.spin(!1),a.zoomTo();const n=a.getView();n&&Array.isArray(n)&&(n[4]=0,n[5]=0,n[6]=0,n[7]=1,a.setView(n)),a.render()}}return D(()=>{const o=document.querySelectorAll(".case-card");o.length>0&&g.fromTo(o,{opacity:0,y:50,scale:.95},{opacity:1,y:0,scale:1,stagger:.2,duration:.8,ease:"power3.out",delay:.3}),g.fromTo(".hero-title",{opacity:0,y:30},{opacity:1,y:0,duration:1,ease:"power3.out"}),g.fromTo(".hero-badge",{opacity:0,scale:.8},{opacity:1,scale:1,duration:.6,ease:"back.out(1.7)",delay:.2}),g.to(".floating-particle",{y:-20,duration:2,repeat:-1,yoyo:!0,ease:"sine.inOut",stagger:.2}),E()}),P(()=>{c.forEach(o=>{o&&o.spin(!1)}),c=[]}),(o,a)=>{const n=G("router-link");return A(),d("div",q,[t("div",j,[a[1]||(a[1]=t("div",{class:"absolute top-1/4 left-1/4 w-96 h-96 bg-cyan-500/10 rounded-full blur-3xl animate-pulse"},null,-1)),a[2]||(a[2]=t("div",{class:"absolute bottom-1/4 right-1/4 w-96 h-96 bg-purple-500/10 rounded-full blur-3xl animate-pulse",style:{"animation-delay":"1s"}},null,-1)),a[3]||(a[3]=t("div",{class:"absolute top-1/2 left-1/2 w-64 h-64 bg-blue-500/10 rounded-full blur-3xl animate-pulse",style:{"animation-delay":"2s"}},null,-1)),a[4]||(a[4]=t("div",{class:"absolute inset-0 bg-[linear-gradient(rgba(34,211,238,0.03)_1px,transparent_1px),linear-gradient(90deg,rgba(34,211,238,0.03)_1px,transparent_1px)] bg-[size:60px_60px]"},null,-1)),(A(),d(b,null,v(20,e=>t("div",{key:e,class:s(["floating-particle absolute w-1 h-1 rounded-full",[e%3===0?"bg-cyan-400":e%3===1?"bg-purple-400":"bg-blue-400"]]),style:I({left:`${Math.random()*100}%`,top:`${Math.random()*100}%`,opacity:.3+Math.random()*.4,animationDelay:`${Math.random()*2}s`})},null,6)),64))]),a[17]||(a[17]=y('<section class="relative z-10 px-6 py-20" data-v-f5a8a883><div class="mx-auto max-w-6xl text-center" data-v-f5a8a883><div class="hero-badge mb-6 inline-flex items-center gap-2 rounded-full border border-amber-500/30 bg-amber-500/10 px-5 py-2 backdrop-blur-sm" data-v-f5a8a883><span class="relative flex h-2 w-2" data-v-f5a8a883><span class="absolute inline-flex h-full w-full animate-ping rounded-full bg-amber-400 opacity-75" data-v-f5a8a883></span><span class="relative inline-flex h-2 w-2 rounded-full bg-amber-500" data-v-f5a8a883></span></span><span class="text-sm font-medium text-amber-300" data-v-f5a8a883>Case Studies</span></div><h1 class="hero-title mb-6 text-5xl font-bold text-[rgb(var(--text-heading))] md:text-7xl" data-v-f5a8a883> Proven <span class="bg-gradient-to-r from-amber-400 via-orange-400 to-blue-400 bg-clip-text text-transparent animate-gradient" data-v-f5a8a883>Results</span></h1><p class="hero-title mx-auto max-w-3xl text-xl text-[rgb(var(--text-body))] leading-relaxed" data-v-f5a8a883> Explore our <span class="text-cyan-400" data-v-f5a8a883>AI-designed therapeutics</span> with interactive 3D molecular viewers. Rotate, zoom, and examine the structures that are advancing medicine. </p><div class="mt-8 flex items-center justify-center gap-2 text-sm text-[rgb(var(--text-muted))]" data-v-f5a8a883><svg class="w-5 h-5 animate-bounce" fill="none" stroke="currentColor" viewBox="0 0 24 24" data-v-f5a8a883><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M15 15l-2 5L9 9l11 4-5 2zm0 0l5 5M7.188 2.239l.777 2.897M5.136 7.965l-2.898-.777M13.95 4.05l-2.122 2.122m-5.657 5.656l-2.12 2.122" data-v-f5a8a883></path></svg><span data-v-f5a8a883>Click and drag on molecules to rotate • Scroll to zoom</span></div></div></section>',1)),t("section",W,[t("div",J,[t("div",K,[(A(),d(b,null,v(M,(e,r)=>t("div",{key:e.id,class:"case-card group"},[t("div",{class:s(["relative rounded-3xl border border-[rgb(var(--border-subtle))/0.5] bg-gradient-to-br from-[rgb(var(--bg-card))/0.9] to-[rgb(var(--bg-card))/0.5] p-1 backdrop-blur-xl overflow-hidden transition-all duration-500 hover:border-[rgb(var(--border-muted))/0.5]",[e.color==="cyan"?"hover:shadow-2xl hover:shadow-cyan-500/20":"",e.color==="purple"?"hover:shadow-2xl hover:shadow-purple-500/20":"",e.color==="pink"?"hover:shadow-2xl hover:shadow-blue-500/20":"",e.color==="emerald"?"hover:shadow-2xl hover:shadow-emerald-500/20":"",e.color==="amber"?"hover:shadow-2xl hover:shadow-amber-500/20":""]])},[t("div",{class:s(["absolute inset-0 opacity-0 transition-opacity duration-500 group-hover:opacity-100",[e.color==="cyan"?"bg-gradient-to-br from-cyan-500/10 via-transparent to-transparent":"",e.color==="purple"?"bg-gradient-to-br from-purple-500/10 via-transparent to-transparent":"",e.color==="pink"?"bg-gradient-to-br from-blue-500/10 via-transparent to-transparent":"",e.color==="emerald"?"bg-gradient-to-br from-emerald-500/10 via-transparent to-transparent":"",e.color==="amber"?"bg-gradient-to-br from-amber-500/10 via-transparent to-transparent":""]])},null,2),t("div",$,[t("div",{class:s(r%2===1?"lg:order-2":"")},[t("div",Q,[t("span",{class:s(["rounded-full px-4 py-1.5 text-xs font-semibold tracking-wide uppercase ring-1",[e.color==="cyan"?"bg-cyan-500/10 text-cyan-400 ring-cyan-500/30":"",e.color==="purple"?"bg-purple-500/10 text-purple-400 ring-purple-500/30":"",e.color==="pink"?"bg-blue-500/10 text-blue-400 ring-blue-500/30":"",e.color==="emerald"?"bg-emerald-500/10 text-emerald-400 ring-emerald-500/30":"",e.color==="amber"?"bg-amber-500/10 text-amber-400 ring-amber-500/30":""]])},i(e.category),3)]),t("h2",Z,i(e.title),1),t("p",X,[a[5]||(a[5]=t("svg",{class:"w-4 h-4",fill:"none",stroke:"currentColor",viewBox:"0 0 24 24"},[t("path",{"stroke-linecap":"round","stroke-linejoin":"round","stroke-width":"2",d:"M19 21V5a2 2 0 00-2-2H7a2 2 0 00-2 2v16m14 0h2m-2 0h-5m-9 0H3m2 0h5M9 7h1m-1 4h1m4-4h1m-1 4h1m-5 10v-5a1 1 0 011-1h2a1 1 0 011 1v5m-4 0h4"})],-1)),p(" "+i(e.partner),1)]),t("p",e0,i(e.description),1),e.moleculeType!=="drugTable"&&e.moleculeType!=="mrnaVisualization"?(A(),d("div",t0,[t("p",a0,i(e.moleculeType==="smallMolecule"?"SMILES Structure":"Peptide Sequence"),1),t("p",{class:s(["font-mono text-sm tracking-wider break-all",[e.color==="cyan"?"text-cyan-400":"",e.color==="purple"?"text-purple-400":"",e.color==="pink"?"text-blue-400":"",e.color==="emerald"?"text-emerald-400":"",e.color==="amber"?"text-amber-400":""]])},i(e.sequence),3)])):h("",!0),t("div",r0,[(A(!0),d(b,null,v(e.results,l=>(A(),d("div",{key:l.label,class:s(["text-center p-4 rounded-xl bg-[rgb(var(--bg-card-muted))/0.3] border border-[rgb(var(--border-muted))/0.3] transition-all duration-300 hover:scale-105",[e.color==="cyan"?"hover:border-cyan-500/30":"",e.color==="purple"?"hover:border-purple-500/30":"",e.color==="pink"?"hover:border-blue-500/30":"",e.color==="emerald"?"hover:border-emerald-500/30":"",e.color==="amber"?"hover:border-amber-500/30":""]])},[t("div",{class:s(["text-2xl lg:text-3xl font-bold mb-1",[e.color==="cyan"?"text-cyan-400":"",e.color==="purple"?"text-purple-400":"",e.color==="pink"?"text-blue-400":"",e.color==="emerald"?"text-emerald-400":"",e.color==="amber"?"text-amber-400":""]])},i(l.metric),3),t("div",o0,i(l.label),1)],2))),128))])],2),t("div",{class:s(r%2===1?"lg:order-1":"")},[t("div",l0,[e.moleculeType==="drugTable"?(A(),d("div",n0,[t("div",s0,[(A(!0),d(b,null,v(Object.keys(O),l=>(A(),d("button",{key:l,onClick:f=>x.value=l,class:s(["px-3 py-1.5 rounded-lg text-xs font-medium transition-all",x.value===l?"bg-emerald-500/20 text-emerald-300 ring-1 ring-emerald-500/50":"bg-[rgb(var(--bg-card-muted))/0.5] text-[rgb(var(--text-body))] hover:bg-[rgb(var(--border-muted))/0.5]"])},i(l),11,i0))),128))]),t("div",d0,[t("table",A0,[a[6]||(a[6]=t("thead",null,[t("tr",{class:"border-b border-[rgb(var(--border-muted))/0.5]"},[t("th",{class:"text-left py-2 px-2 text-[rgb(var(--text-body))] font-medium text-xs"},"Drug Name"),t("th",{class:"text-center py-2 px-2 text-[rgb(var(--text-body))] font-medium text-xs"},"pIC50"),t("th",{class:"text-center py-2 px-2 text-[rgb(var(--text-body))] font-medium text-xs"},"FDA Rank"),t("th",{class:"text-center py-2 px-2 text-[rgb(var(--text-body))] font-medium text-xs"},"Antiviral Rank")])],-1)),t("tbody",null,[(A(!0),d(b,null,v(O[x.value],(l,f)=>(A(),d("tr",{key:l.drug,class:"border-b border-[rgb(var(--border-subtle))/0.5] hover:bg-[rgb(var(--bg-card-muted))/0.3] transition-colors"},[t("td",c0,[t("span",p0,[t("span",b0,i(f+1),1),p(" "+i(l.drug),1)])]),t("td",v0,[t("span",x0,i(l.pIC50.toFixed(2)),1)]),t("td",u0,"#"+i(l.rankFDA),1),t("td",g0,[t("span",m0,"#"+i(l.rankAntiviral),1)])]))),128))])])]),t("div",C0,[t("p",T0,"Top 5 candidates for "+i(x.value)+" target",1),a[7]||(a[7]=t("div",{class:"px-3 py-1.5 rounded-lg text-xs font-medium bg-emerald-500/20 text-emerald-300"},[t("span",{class:"inline-block w-2 h-2 rounded-full animate-pulse mr-2 bg-emerald-400"}),p(" AI Predictions ")],-1))])])):e.moleculeType==="mrnaVisualization"?(A(),d("div",O0,a[8]||(a[8]=[y('<h4 class="text-lg font-semibold text-[rgb(var(--text-heading))] mb-4 flex items-center gap-2" data-v-f5a8a883><svg class="w-5 h-5 text-cyan-400" fill="none" stroke="currentColor" viewBox="0 0 24 24" data-v-f5a8a883><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 19v-6a2 2 0 00-2-2H5a2 2 0 00-2 2v6a2 2 0 002 2h2a2 2 0 002-2zm0 0V9a2 2 0 012-2h2a2 2 0 012 2v10m-6 0a2 2 0 002 2h2a2 2 0 002-2m0 0V5a2 2 0 012-2h2a2 2 0 012 2v14a2 2 0 01-2 2h-2a2 2 0 01-2-2z" data-v-f5a8a883></path></svg> Benchmark Results </h4><div class="overflow-x-auto" data-v-f5a8a883><table class="w-full text-xs" data-v-f5a8a883><thead data-v-f5a8a883><tr class="border-b border-[rgb(var(--border-muted))/0.5]" data-v-f5a8a883><th class="text-left py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>Model</th><th class="text-center py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>E.coli</th><th class="text-center py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>MLOS</th><th class="text-center py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>iCodon</th><th class="text-center py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>Tc-Ribo</th><th class="text-center py-2 px-1 text-[rgb(var(--text-body))] font-medium" data-v-f5a8a883>mRFP</th></tr></thead><tbody data-v-f5a8a883><tr class="border-b border-[rgb(var(--border-subtle))/0.3]" data-v-f5a8a883><td colspan="6" class="py-1.5 px-1 text-[rgb(var(--text-muted))] text-xs italic" data-v-f5a8a883>Nucleotide-Based</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3] hover:bg-[rgb(var(--bg-card-muted))/0.2]" data-v-f5a8a883><td class="py-1.5 px-1 text-[rgb(var(--text-primary))]" data-v-f5a8a883>RNA-FM</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.43</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-muted))]" data-v-f5a8a883>-</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.34</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.58</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.80</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3] hover:bg-[rgb(var(--bg-card-muted))/0.2]" data-v-f5a8a883><td class="py-1.5 px-1 text-[rgb(var(--text-primary))]" data-v-f5a8a883>Aido mRNA</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.576</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.504</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.472</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.492</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.683</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3] hover:bg-[rgb(var(--bg-card-muted))/0.2]" data-v-f5a8a883><td class="py-1.5 px-1 text-[rgb(var(--text-primary))]" data-v-f5a8a883>mRNA-FM</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-muted))]" data-v-f5a8a883>-</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.509</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.458</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.690</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.564</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3]" data-v-f5a8a883><td colspan="6" class="py-1.5 px-1 text-[rgb(var(--text-muted))] text-xs italic" data-v-f5a8a883>Codon-Based</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3] hover:bg-[rgb(var(--bg-card-muted))/0.2]" data-v-f5a8a883><td class="py-1.5 px-1 text-[rgb(var(--text-primary))]" data-v-f5a8a883>CodonBert</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.57</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.543</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.350</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.502</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.832</td></tr><tr class="border-b border-[rgb(var(--border-subtle))/0.3] hover:bg-[rgb(var(--bg-card-muted))/0.2]" data-v-f5a8a883><td class="py-1.5 px-1 text-[rgb(var(--text-primary))]" data-v-f5a8a883>HELM (MLM)</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-muted))]" data-v-f5a8a883>-</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.701</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.525</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.626</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-body))]" data-v-f5a8a883>0.822</td></tr><tr class="border-b border-cyan-500/30 bg-cyan-500/5" data-v-f5a8a883><td class="py-1.5 px-1 text-cyan-300 font-semibold" data-v-f5a8a883>Equi-mRNA (5M)</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-primary))]" data-v-f5a8a883>0.581</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-primary))]" data-v-f5a8a883>0.705</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-primary))]" data-v-f5a8a883>0.519</td><td class="py-1.5 px-1 text-center font-bold text-cyan-400" data-v-f5a8a883>0.764</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-primary))]" data-v-f5a8a883>0.853</td></tr><tr class="bg-gradient-to-r from-cyan-500/10 to-purple-500/10" data-v-f5a8a883><td class="py-1.5 px-1 text-cyan-300 font-bold" data-v-f5a8a883>Equi-mRNA (15M)</td><td class="py-1.5 px-1 text-center font-bold text-cyan-400" data-v-f5a8a883>0.613</td><td class="py-1.5 px-1 text-center font-bold text-cyan-400" data-v-f5a8a883>0.710</td><td class="py-1.5 px-1 text-center font-bold text-cyan-400" data-v-f5a8a883>0.537</td><td class="py-1.5 px-1 text-center text-[rgb(var(--text-primary))]" data-v-f5a8a883>0.737</td><td class="py-1.5 px-1 text-center font-bold text-cyan-400" data-v-f5a8a883>0.855</td></tr></tbody></table></div><div class="mt-4 pt-3 border-t border-[rgb(var(--border-muted))/0.5] flex items-center justify-between" data-v-f5a8a883><p class="text-xs text-[rgb(var(--text-muted))]" data-v-f5a8a883>Bold = Best performance on dataset</p><a href="https://arxiv.org/abs/2508.15103" target="_blank" rel="noopener noreferrer" class="inline-flex items-center gap-1 text-xs text-cyan-400 hover:text-cyan-300 transition-colors" data-v-f5a8a883> NeurIPS 2025 Paper <svg class="w-3 h-3" fill="none" stroke="currentColor" viewBox="0 0 24 24" data-v-f5a8a883><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14" data-v-f5a8a883></path></svg></a></div>',3)]))):(A(),d("div",{key:2,class:s(["relative aspect-square rounded-2xl overflow-hidden border border-[rgb(var(--border-muted))/0.5] bg-[rgb(var(--bg-card))/0.8]",[e.color==="cyan"?"shadow-lg shadow-cyan-500/10":"",e.color==="purple"?"shadow-lg shadow-purple-500/10":"",e.color==="pink"?"shadow-lg shadow-blue-500/10":"",e.color==="amber"?"shadow-lg shadow-amber-500/10":""]])},[m.value[r]?(A(),d("div",M0,[t("div",f0,[t("div",{class:s(["w-12 h-12 mx-auto mb-4 border-4 border-[rgb(var(--border-muted))] rounded-full animate-spin",[e.color==="cyan"?"border-t-cyan-500":"",e.color==="purple"?"border-t-purple-500":"",e.color==="pink"?"border-t-blue-500":"",e.color==="amber"?"border-t-amber-500":""]])},null,2),a[9]||(a[9]=t("p",{class:"text-sm text-[rgb(var(--text-muted))]"},"Loading 3D structure...",-1))])])):h("",!0),t("div",{ref_for:!0,ref:l=>T.value[r]=l,class:"absolute inset-0 w-full h-full min-h-[350px] lg:min-h-[450px]",style:{"z-index":"1"},onMouseenter:l=>k(r),onMouseleave:l=>L(r)},null,40,y0),t("div",h0,[t("div",N0,[t("button",{onClick:l=>S(r),onMousedown:a[0]||(a[0]=_(()=>{},["stop","prevent"])),type:"button",class:"relative px-3 py-1.5 rounded-lg text-xs font-medium bg-[rgb(var(--bg-card-muted))] text-[rgb(var(--text-primary))] hover:bg-[rgb(var(--border-muted))] active:bg-[rgb(var(--border-muted))] transition-colors backdrop-blur-sm cursor-pointer select-none",style:{"z-index":"9999","pointer-events":"auto !important",position:"relative"}},a[10]||(a[10]=[t("svg",{class:"w-4 h-4 inline-block mr-1",fill:"none",stroke:"currentColor",viewBox:"0 0 24 24"},[t("path",{"stroke-linecap":"round","stroke-linejoin":"round","stroke-width":"2",d:"M4 4v5h.582m15.356 2A8.001 8.001 0 004.582 9m0 0H9m11 11v-5h-.581m0 0a8.003 8.003 0 01-15.357-2m15.357 2H15"})],-1),p(" Reset ",-1)]),40,E0)]),t("div",{class:s(["px-3 py-1.5 rounded-lg text-xs font-medium backdrop-blur-sm",[e.color==="cyan"?"bg-cyan-500/20 text-cyan-300":"",e.color==="purple"?"bg-purple-500/20 text-purple-300":"",e.color==="pink"?"bg-blue-500/20 text-blue-300":"",e.color==="amber"?"bg-amber-500/20 text-amber-300":""]])},[t("span",{class:s(["inline-block w-2 h-2 rounded-full animate-pulse mr-2",[e.color==="cyan"?"bg-cyan-400":"",e.color==="purple"?"bg-purple-400":"",e.color==="pink"?"bg-blue-400":"",e.color==="amber"?"bg-amber-400":""]])},null,2),a[11]||(a[11]=p(" Interactive 3D ",-1))],2)])],2)),t("div",{class:s(["absolute -top-4 -right-4 w-24 h-24 rounded-full blur-2xl opacity-30",[e.color==="cyan"?"bg-cyan-500":"",e.color==="purple"?"bg-purple-500":"",e.color==="pink"?"bg-blue-500":"",e.color==="emerald"?"bg-emerald-500":"",e.color==="amber"?"bg-amber-500":""]])},null,2),t("div",{class:s(["absolute -bottom-4 -left-4 w-32 h-32 rounded-full blur-3xl opacity-20",[e.color==="cyan"?"bg-blue-500":"",e.color==="purple"?"bg-blue-500":"",e.color==="pink"?"bg-orange-500":"",e.color==="emerald"?"bg-teal-500":"",e.color==="amber"?"bg-orange-500":""]])},null,2)])],2)])],2)])),64))])])]),t("section",k0,[t("div",L0,[t("div",S0,[a[15]||(a[15]=t("div",{class:"absolute inset-0 bg-gradient-to-r from-cyan-500/5 via-purple-500/5 to-blue-500/5"},null,-1)),a[16]||(a[16]=t("div",{class:"absolute top-0 left-1/2 -translate-x-1/2 w-96 h-96 bg-gradient-to-b from-cyan-500/20 to-transparent rounded-full blur-3xl"},null,-1)),t("div",R0,[a[13]||(a[13]=t("h2",{class:"mb-6 text-3xl font-bold text-[rgb(var(--text-heading))] md:text-4xl"},[p(" Ready to Start Your "),t("span",{class:"bg-gradient-to-r from-cyan-400 via-purple-400 to-blue-400 bg-clip-text text-transparent"},"Success Story"),p("? ")],-1)),a[14]||(a[14]=t("p",{class:"mb-8 text-lg text-[rgb(var(--text-body))] max-w-2xl mx-auto"}," Join leading pharmaceutical and biotech companies using DeepBio Scientific to accelerate therapeutic discovery with AI-powered molecular design. ",-1)),t("div",w0,[V(n,{to:"/contact",class:"group relative overflow-hidden rounded-full bg-gradient-to-r from-cyan-500 to-purple-600 px-8 py-4 font-semibold text-white shadow-lg shadow-cyan-500/30 transition-all hover:shadow-cyan-500/50"},{default:B(()=>a[12]||(a[12]=[t("span",{class:"relative z-10"},"Start a Partnership",-1),t("div",{class:"absolute inset-0 bg-gradient-to-r from-purple-600 to-blue-600 opacity-0 transition-opacity group-hover:opacity-100"},null,-1)])),_:1,__:[12]})])])])])])])}}}),I0=z(H0,[["__scopeId","data-v-f5a8a883"]]);export{I0 as default};
